Application to aid in the identification of non-conformities, on molded glass bottles, for the pharmaceutical industry
On the occasion of the CPhI WW 2019 trade fair, SGD Pharma launched the first application to aid in the identification of non-conformities, on molded glass bottles, intended for the pharmaceutical industry.
The result of development work between the quality and marketing departments of SGD Pharma, this new digital tool makes it possible to identify non-conformities that may be encountered during an inspection on receipt or during an inspection in progress or at the end of the primary packaging production. The SGD Pharma App is a true example of the commitment of the manufacturer's quality and technical departments and of its continuous improvement. It also reflects its transparent collaboration with its clients in a common quest to protect patient health.
Specialist in molded glass pharmaceutical packaging for the healthcare sector, SGD Pharma makes the quality of its products a key focus of its investment actions. Within the framework of this policy, the application aims to optimize and harmonize customer / supplier relationships by helping quality controllers, sales representatives, technical staff and buyers to quickly and easily identify non- conformities that can be found on bottles, in molded glass, intended for the pharmaceutical industry.
Available free of charge from the Apple Store and the Play Store, the user only needs a few clicks to create an account and have unlimited access to a visual compilation, in 2D, of the most frequently encountered non-conformities. Navigation in the App is done first by administration route (parenteral, oral or nasal), then the user can refine his search by location, or by class of non-compliance corresponding to the various consequences for the end customer. or on packaging lines (critical, major or aspect). Once the non-conformity has been identified, the user then accesses a dedicated page including a visual, a definition, its class and its associated acceptable quality level (AQL), this in connection with the international standard ISO 2859-1. The SGD Pharma standards are then crossed with those of the two quality references recognized and accepted in the industry: the technical report 43 1/2 of the Parenteral Drug Association (PDA) and the list of non-conformities of the molded glass containers of the Edito-Cantor-Verlag (ECV). According to Quentin Ritter, Quality Project Manager at SGD Pharma, “ this application project was initiated following the increasingly frequent demand from our customers to be trained in glass defects. It is indeed crucial for them to be able to identify them and recognize them quickly in order to improve the control processes and to take the right decision according to the consequences of each ” .
“The wish of SGD Pharma, adds Emmanuel Lepitre, development and quality manager, in addition to improving safety for the end user, is to have our quality standards recognized as benchmarks in the molded glass market in the pharmaceutical industry. In addition, the application responds to the ever growing trend of zero defects, including in cosmetic quality, to allow hospital staff to have no doubts about the administration of a flawless drug to patients. With this application, open to all professionals in the sector, but designed upstream for its customers, SGD Pharma aims to reach all the services of a single company, from the buyer to the on-line controller. "